BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 394011)

  • 1. T and B lymphocytes in lymph nodes and spleen of patients with Hodgkin's disease.
    Berényi E; Sonkoly I; Pálóczi K; Balázs G; Szegedi G
    Neoplasma; 1979; 26(3):307-13. PubMed ID: 394011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The T and B lymphocyte content of lymph nodes and spleen in Hodgkin's disease.
    Stathopoulos G; Papamichail M; Peckham MJ; Davies AJ; Holborow EJ
    Br J Exp Pathol; 1977 Dec; 58(6):712-6. PubMed ID: 305255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SPLEEN/PATHOL.
    Bukowski RM; Noguchi S; Hewlett JS; Deodhar S
    Am J Clin Pathol; 1976 Jan; 65(1):30-9. PubMed ID: 1082240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nodular lymphocyte predominance type of Hodgkin's disease is a germinal center lymphoma.
    Timens W; Visser L; Poppema S
    Lab Invest; 1986 Apr; 54(4):457-61. PubMed ID: 3083157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T and B lymphocytes and Reed-Sternberg cells in Hodgkin's disease lymph nodes and spleens.
    Payne SV; Jones DB; Haegert DG; Smith JL; Wright DH
    Clin Exp Immunol; 1976 May; 24(2):280-6. PubMed ID: 1084241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunoregulatory subpopulations of T-lymphocytes and their distribution in the peripheral blood, lymph nodes and spleen of patients with lymphogranulomatosis].
    Kharabadze MV; Tabagari DZ
    Ter Arkh; 1989; 61(7):30-2. PubMed ID: 2686065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Proportion of B- and T-lymphocytes in lymph nodes removed from patients with Hodgkin's disease].
    Pluzzańska A; Robak T; Szadowska A; Kabza R; Tume Z; Maciejczyk J; Mazurowa A
    Acta Haematol Pol; 1978; 9(1):19-24. PubMed ID: 307324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphocyte subpopulations of lymph nodes and spleens in Hodgkin's disease.
    Pinkus GS; Barbuto D; Said JW; Churchill WH
    Cancer; 1978 Sep; 42(3):1270-9. PubMed ID: 308838
    [No Abstract]   [Full Text] [Related]  

  • 9. [Cytotoxicity of effector cells of the peripheral blood, lymph nodes and spleen in Hodgkin's disease].
    Blokhina NG; Bykovskaia SN; Kharabadze MV; Kupriianova TA; Agafonov VA
    Biull Eksp Biol Med; 1989 Nov; 108(11):600-3. PubMed ID: 2633827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hodgkin's disease in children: investigation of T and B lymphocytes.
    Ilyin NV; Kolygin BA; Letsky VB; Fedoreev GA; Zubzhitsky YN
    Neoplasma; 1978; 25(1):75-81. PubMed ID: 305545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B lymphocytes in untreated patients with malignant lymphoma and Hodgkin's disease.
    Gajl-Peczalska KJ; Hansen JA; Bloomfield CD; Good RA
    J Clin Invest; 1973 Dec; 52(12):3064-73. PubMed ID: 4201499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparison of the immunological indices of the peripheral blood and lymph nodes in lymphogranulomatosis in children].
    Voĭtenkov BO; Gavrilenkova LP
    Vopr Onkol; 1985; 31(7):83-7. PubMed ID: 3875182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural killer activity in spleens and lymph nodes from patients with Hodgkin's disease.
    Ruco LP; Procopio A; Uccini S; Marcorelli E; Baroni CD
    Cancer Res; 1982 May; 42(5):2063-8. PubMed ID: 6175405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunologic parameters in childhood Hodgkin's disease II. T and B lymphocytes in the peripheral blood of normal children and in the spleen and peripheral blood of children with Hodgkin's disease.
    de Sousa M; Tan CT; Siegal FP; Filippa DA; Tan R; Good RA
    Pediatr Res; 1978 Feb; 12(2):143-7. PubMed ID: 306089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Proportions and absolute count of T- and B-lymphocytes in peripheral blood and their blastic transformation induced by mitogens in splenectomized and non-splenectomized patients with Hodgkin's disease].
    Pluzańska A
    Acta Haematol Pol; 1978; 9(1):37-44. PubMed ID: 307325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunological markers of peripheral blood and lymph node lymphocytes in Hodgkin's disease.
    González M; Hernández F; San Miguel JF; Moraleda JM; Caballero MD; López Borrasca A
    Neoplasma; 1985; 32(2):191-8. PubMed ID: 4000308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hodgkin's disease. Histology--immunohistology--immunology].
    Möller P
    Norm Pathol Anat (Stuttg); 1986; 51():1-77. PubMed ID: 3495783
    [No Abstract]   [Full Text] [Related]  

  • 18. In vitro studies of axillary lymph node cells in patients with breast cancer.
    Tsakraklides E; Tsakraklides V; Ashikari H; Rosen PP; Siegal FP; Robbins GF; Good RA
    J Natl Cancer Inst; 1975 Mar; 54(3):549-56. PubMed ID: 1079055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. E-rosette inhibiting substance in Hodgkin's disease spleen extracts.
    Bieber MM; Fuks Z; Kaplan HS
    Clin Exp Immunol; 1977 Sep; 29(3):369-75. PubMed ID: 201408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue T-lymphocytes in untreated Hodgkin's disease: morphologic and functional correlations in spleens and lymph nodes.
    Baroni CD; Ruco L; Uccini S; Foschi A; Occhionero M; Marcorelli E
    Cancer; 1982 Jul; 50(2):259-68. PubMed ID: 6979382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.